Polskie Radio covers Eli Lilly trial data on retatrutide and the weight loss it produced, with few details given in the listing.
Recap by typeshit. Full story at www.polskieradio.pl.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
A Facebook roundup lines up CagriSema's REIMAGINE 2 numbers, with time in range rising from 52.3% to 88.0% by week 68, next to retatrutide's TRIUMPH-2 results.
The Wall Street Journal reports black-market producers are pitching Americans substances for tanning, tissue repair and weight loss.
Loading…